enfr

Atlanpole Biotherapies
Our network
News & Events
- Events
- News
Services
Employment
- Jobs
- CVS
Contact

News

Inflectis-logo

Home > InFlectis BioScience announces favorable results for IFB-088 Phase 1 Single Ascending Dose clinical trial > Inflectis-logo

16 May 2019

All news

Facebook
Linkedin
Twitter
Mail

< Previous post

Back to list

Biotech / Pharma

MedTech

Digital Health

Disease Prevention

Jobs
Legal Statement
Privacy policy for personal data

Events
News
Tailored services for international partners
Legal Statement
Privacy policy for personal data

Find us

Mail